Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

WellPoint's CER Guide Describes How It Will Determine Usefulness Of Studies

Executive Summary

WellPoint has released guidelines for the submission and evaluation of comparative effectiveness research that it will use in reviewing drugs for its formulary
Advertisement

Related Content

Observational Study Guidance Needed For CER – Vanderbilt’s Harrell
Observational Study Guidance Needed For CER – Vanderbilt’s Harrell
CER Could Be A Barrier To Innovation, Venture Capitalist Says
CER Could Be A Barrier To Innovation, Venture Capitalist Says
Large Payers, Including CMS, PBMs, Mostly Absent From PCORI Board
Large Payers, Including CMS, PBMs, Mostly Absent From PCORI Board
CER To Play A Larger Role In Investment Decisions – Merck's McElwee
WellPoint Plans To Seek Pharma Partners For Outcomes-Based Contracting: An Interview With WellPoint's Brian Sweet
WellPoint Plans CER Guidance, Building On Progress With Outcomes Data
WellPoint Plans CER Guidance, Building On Progress With Outcomes Data

Topics

Advertisement
UsernamePublicRestriction

Register

PS052265

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel